Leavitt Equity Partners, a healthcare focused private equity firm, closed its third fund, Leavitt Equity Partners III (LEP III), which raised more than $180 million, surpassing the investment firm’s initial target of $150 million.
“We are delighted with the outcome of this fundraise and the strong support from both existing and new investors,” Taylor Leavitt, managing partner and CEO of Leavitt Equity Partners, said.
LEP III’s limited partner base consists primarily of healthcare partners, in addition to insurance companies, foundations and family offices. As with predecessor funds, LEP III seeks to invest in lower middle-market healthcare companies with a focus on services, care models and technologies that bring value to healthcare in the form of lower costs, better quality and better access.
“We believe our ability to bring deep healthcare policy and strategic expertise enables significant growth potential for our portfolio companies as we look to support a more value-driven healthcare future,” Andrew Clark, managing partner of Leavitt Equity Partners, said.
Dorsey & Whitney served as legal advisors to Leavitt Equity Partners in the formation of LEP III.
